Screener
Avalo Therapeutics AVTX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's price / book?
- Avalo Therapeutics (AVTX) reported price / book of 2.2× in Q2 2026.
- How has Avalo Therapeutics's price / book changed year-over-year?
- Avalo Therapeutics's price / book increased by 322.5% year-over-year, from 0.5× to 2.2×.
- What is the long-term trend for Avalo Therapeutics's price / book?
- Over 4 years (2020 to 2025), Avalo Therapeutics's price / book has grown at a -21.0% compound annual growth rate (CAGR), from 10.2× to 4×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Avalo Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude